1. Home
  2. QTTB vs SPCB Comparison

QTTB vs SPCB Comparison

Compare QTTB & SPCB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Q32 Bio Inc.

QTTB

Q32 Bio Inc.

HOLD

Current Price

$6.37

Market Cap

44.3M

Sector

Health Care

ML Signal

HOLD

Logo SuperCom Ltd. (Israel)

SPCB

SuperCom Ltd. (Israel)

HOLD

Current Price

$8.22

Market Cap

39.8M

Sector

Technology

ML Signal

HOLD

Company Overview

Basic Information
Metric
QTTB
SPCB
Founded
2015
1988
Country
United States
Israel
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
44.3M
39.8M
IPO Year
2018
2004

Fundamental Metrics

Financial Performance
Metric
QTTB
SPCB
Price
$6.37
$8.22
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$13.00
N/A
AVG Volume (30 Days)
349.4K
42.9K
Earning Date
05-07-2026
05-13-2026
Dividend Yield
N/A
N/A
EPS Growth
136.78
N/A
EPS
2.42
N/A
Revenue
$53,737,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$27.13
P/E Ratio
$2.64
$10.36
Revenue Growth
N/A
N/A
52 Week Low
$1.38
$5.10
52 Week High
$8.05
$13.57

Technical Indicators

Market Signals
Indicator
QTTB
SPCB
Relative Strength Index (RSI) 54.11 51.35
Support Level $3.49 $7.75
Resistance Level $7.80 $8.69
Average True Range (ATR) 0.93 0.43
MACD -0.13 0.01
Stochastic Oscillator 34.32 72.40

Price Performance

Historical Comparison
QTTB
SPCB

About QTTB Q32 Bio Inc.

Q32 Bio Inc is a clinical-stage biotechnology company focused on developing novel biologics to effectively and safely restore healthy immune balance in patients with autoimmune & inflammatory diseases driven by pathological immune dysfunction. Q32 is advancing antibody-based therapeutic candidates designed to target two central pathways of adaptive & innate immunity. The adaptive immune system is largely composed of T- & B-cell mediated cellular & antibody responses, while the innate immune system is the body's first line of defense employing leukocytes that are responsible for clearing pathogens and cellular debris and modulating T- & B-cell function.

About SPCB SuperCom Ltd. (Israel)

SuperCom Ltd is an Israel-based provider of traditional and digital identity solutions, providing safety, identification, tracking, and security products to governments and organizations. The company comprises three main Strategic Business Units: e-Gov; IoT, which is the key revenue driver; and Cyber Security. The Company's IoT products and solutions reliably identify, track and monitor people or objects in real time, enabling the customers to detect unauthorized movement of people, vehicles and other monitored objects. The geographical segments of the company include Africa, European countries, South America, the United States, Israel, and APAC.

Share on Social Networks: